Science · 1989 · 328 citations · 33 references
Life SciencesImmunologyInfectious DiseasesImmunology Of Infectious DiseasesMonoclonal AntibodiesVaccine ImmunologyAntibody FunctionAntibody-mediated ProtectionAntiviral ImmunityCell-mediated ImmunityHiv Vaccine DevelopmentImmunoglobulin FunctionAcquired Immunodeficiency SyndromeHiv Infection ModelsPathogen Infectivity
Antibodies that enhance human immunodeficiency virus (HIV) infectivity have been found in the blood of infected individuals and in infected or immunized animals. These findings raise serious concern for the development of a safe vaccine against acquired immunodeficiency syndrome. To address the in vivo relevance and mechanism of this phenomenon, antibody-dependent enhancement of HIV infectivity in peripheral blood macrophages, lymphocytes, and human fibroblastoid cells was studied. Neither Leu3a, a monoclonal antibody directed against the CD4 receptor, nor soluble recombinant CD4 even at high concentrations prevented this enhancement. The addition of monoclonal antibody to the Fc receptor III (anti-FcRIII), but not of antibodies that react with FcRI or FcRII, inhibited HIV type 1 and HIV type 2 enhancement in peripheral blood macrophages. Although enhancement of HIV infection in CD4+ lymphocytes could not be blocked by anti-FcRIII, it was inhibited by the addition of human immunoglobulin G aggregates. The results indicate that the FcRIII receptor on human macrophages and possibly another Fc receptor on human CD4+ lymphocytes mediate antibody-dependent enhancement of HIV infectivity and that this phenomenon proceeds through a mechanism independent of the CD4 protein.
33
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Angus Dalgleish, Peter C. L. Beverley, Paul R. Clapham et al. · Nature · 1984 · 3.5K citations
soluble form of CD4 (T4) protein inhibits AIDS virus infection
Keith C. Deen, J. Steven McDougal, Richard Inacker et al. · Nature · 1988 · 526 citations